A Prospective Multi-centre Observational Cohort Study Assessing the Effectiveness of Cortiment for the Treatment of Mild-to-moderate Active Ulcerative Colitis in Routine Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 11 May 2017
At a glance
- Drugs Budesonide (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms CORE Practice
- Sponsors Ferring Pharmaceuticals
- 17 Oct 2016 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 17 Oct 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Feb 2018.
- 26 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.